Showing results (121-130 of 537) with videos related to

Sort By:
Pageof 54
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2016
Induced Apoptosis Investigation in Wild-type and FLT3-ITD Acute Myeloid Leukemia Cells by Nanochannel Electroporation and Single-cell qRT-PCRKeliang Gao, Xiaomeng Huang, Chi-Ling Chiang, et al.
Blood|July 13, 2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaPearlly Yan, David Frankhouser, Mark Murphy, et al.
Blood|February 13, 2009
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1Ramiro Garzon, Shujun Liu, Muller Fabbri, et al.
Blood Advances|July 12, 2021
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)Alison R Walker, Guido Marcucci, Jun Yin, et al.
International Journal of Molecular Sciences|May 25, 2024
BRAF Mutations in Patients with Myeloid Neoplasms: A Cancer Center Multigene Next-Generation Sequencing Analysis ExperienceFei Fei, Caitlin Caporale, Lisa Chang, et al.
American Journal of Hematology|May 12, 2017
Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemiaIbrahim Aldoss, Joo Song, Tracey Stiller, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 28, 2021
Acute Myeloid Leukemia: Historical Perspective and Progress in Research and Therapy Over 5 DecadesHagop M Kantarjian, Nicholas J Short, Amir T Fathi, et al.
Haematologica|March 24, 2018
A novel regimen for relapsed/refractory adult acute myeloid leukemia using a KMT2A partial tandem duplication targeted therapy: results of phase 1 study NCI 8485Alice S Mims, Anjali Mishra, Shelley Orwick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2010
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabineWilliam Blum, Ramiro Garzon, Rebecca B Klisovic, et al.
Cancer Genetics|May 7, 2019
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testingThomas P Slavin, Bradford Coffee, Ryan Bernhisel, et al.
Pageof 54